Swiss stocks - Factors to watch on May 24
ZURICH, May 24 The following are some of the main factors expected to affect Swiss stocks on Wednesday.
July 1 Insmed Inc said a late-stage trial of its experimental lung infection drug showed the therapy was as effective as another approved treatment.
The drug, Arikace, was being tested as a treatment for a bacterial infection in cystic fibrosis patients. The trial met its main goal of showing Arikace was not inferior to Tovi, Novartis's drug for the same infection.
TOKYO, May 24 Chinese stocks fell and the Australian dollar skidded on Wednesday after Moody's downgraded its sovereign credit rating on China, adding to worries about the global impact of slowing growth and rising debt in Asia's economic powerhouse.
MEXICO CITY/NEW YORK, May 24 The newly refurbished Citibanamex branch in Mexico City's affluent Del Valle neighborhood opens into a Scandinavian-chic space where salespeople chat with clients at touch screens. The next room, though, is filled with customers queueing up in front of tellers or waiting on benches. Outside, more line up to use the ATMs.